Axios @axios
Eli Lilly plans on filing an application for an "accelerated approval" of its experimental Alzheimer's treatment with the FDA later this year despite not having completed a late-stage trial. https://t.co/lITqIoV6uu — PolitiTweet.org
Created
Thu Jun 24 16:17:00 +0000 2021
Likes
20
Retweets
7
Source
TweetDeck
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
Eli Lilly plans on filing an application for an "accelerated approval" of its experimental Alzheimer's treatment with the FDA later this year despite not having completed a late-stage trial. https://t.co/lITqIoV6uu — PolitiTweet.org